An Impeccable Audience Quality to Ensure Meaningful Precision Medicine Connections

Just Confirmed to Attend

  • Xencor
  • Pfizer
  • Kelonia Therapeutics
  • Johnson & Johnson Innovative Medicines
  • Bicycle Therapeutics
  • Genmab

 

Teams Attending

  • Acrivon Therapeutics 8
  • AstraZeneca 8
  • Bristol Myers Squibb 23
  • Johnson & Johnson Innovative Medicines 25
  • Novartis 10
  • Takeda 19

Senior Decision-Makers Joining Daily

  • Global Head, Biomarker Development & Operations
  • Global Diagnostic Lead
  • Head & Director, Scientific, Precision Medicine
  • Vice President, Precision Medicine

Real-Time Industry Participation Trends

Biopharma leaders have already confirmed from 75+ drug developer organizations

With 40% of last year’s total pharma and biotech accounts secured in just 6 weeks, momentum is building fast

Brand-new companies attending include Candel Therapeutics, Kelonia Therapeutics, OncoC4, Rhore and Vividion Therapeutics

Audience Breakdown

Take a sneak preview at the 850+ senior stakeholders joining us for the 16th World Clinical Biomarkers & Companion Diagnostics Summit.

Company Types
Types of Companies Attending
Seniority
Seniority of Attendees
Expertise & Job Titles
CDx Word Cloud (2)

*Statistics Taken from 15th World Clinical Biomarkers & Companion Diagnostics Summit

See the Full Event Line-Up